Patents by Inventor Kurt Strand

Kurt Strand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090263877
    Abstract: The invention provides a process for the production of biomass by culturing a microorganism in an aqueous liquid culture medium circulating in a loop reactor having an effluent gas removal zone where from carbon dioxide-containing effluent gas is removed from the reactor and upstream thereof a degassing zone in which a driving gas is introduced to drive carbon dioxide in the liquid phase into a separable effluent gas phase and having upstream of said degassing zone a nutrient gas introduction zone in which oxygen is introduced into the reactor and mixed with the liquid culture medium therein, characterized in that oxygen introduction in said nutrient gas introduction zone is effected at a plurality of locations along the flow path through said loop reactor at a rate such that the average dissolved oxygen content of said liquid culture medium measured using a polarographic oxygen electrode does not exceed 25 ppm.
    Type: Application
    Filed: June 30, 2009
    Publication date: October 22, 2009
    Applicant: STATOIL ASA
    Inventors: Henrik ERIKSEN, Kurt STRAND, Lars JORGENSEN
  • Patent number: 7579163
    Abstract: The invention provides a process for the production of biomass by culturing a microorganism in an aqueous liquid culture medium circulating in a loop reactor having an effluent gas removal zone where from carbon dioxide-containing effluent gas is removed from the reactor and upstream thereof a degassing zone in which a driving gas is introduced to drive carbon dioxide in the liquid phase into a separable effluent gas phase and having upstream of said degassing zone a nutrient gas introduction zone in which oxygen is introduced into the reactor and mixed with the liquid culture medium therein, characterised in that oxygen introduction in said nutrient gas introduction zone is effected at a plurality of locations along the flow path through said loop reactor at a rate such that the average dissolved oxygen content of said liquid culture medium measured using a polarographic oxygen electrode does not exceed 25 ppm.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: August 25, 2009
    Assignee: STATOIL ASA
    Inventors: Henrik Eriksen, Kurt Strand, Lars Jørgensen
  • Publication number: 20040241790
    Abstract: The invention provides a process for the production of biomass by culturing a microorganism in an aqueous liquid culture medium circulating in a loop reactor having an effluent gas removal zone where from carbon dioxide-containing effluent gas is removed from the reactor and upstream thereof a degassing zone in which a driving gas is introduced to drive carbon dioxide in the liquid phase into a separable effluent gas phase and having upstream of said degassing zone a nutrient gas introduction zone in which oxygen is introduced into the reactor and mixed with the liquid culture medium therein, characterised in that oxygen introduction in said nutrient gas introduction zone is effected at a plurality of locations along the flow path through said loop reactor at a rate such that the average dissolved oxygen content of said liquid culture medium measured using a polarographic oxygen electrode does not exceed 25 ppm.
    Type: Application
    Filed: July 9, 2004
    Publication date: December 2, 2004
    Inventors: Henrik Eriksen, Kurt Strand, Lars Jorgensen
  • Patent number: 6051375
    Abstract: This invention relates to polynucleotides encoding Glycoprotein B from the RFHV/KSHV subfamily of gamma herpes viruses, three members of which are characterized in detail. DNA extracts were obtained from Macaque nemestrina and Macaque mulatta monkeys affected with retroperitoneal fibromatosis (RF), and human AIDS patients affected with Kaposi's sarcoma (KS). The extracts were amplified using consensus-degenerate oligonucleotide probes designed from known protein and DNA sequences of gamma herpes viruses. The nucleotide sequences of a 319 base pair fragment are about 76% identical between RFHV1 and KSHV, and about 60-63% identical with the closest related gamma herpes viruses outside the RFHV/KSHV subfamily. Protein sequences encoded within these fragments are are about 91% identical between RFHV1 and KSHV, and <.about.65% identical to that of other gamma herpes viruses.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: April 18, 2000
    Inventors: Timothy M. Rose, Marnix L. Bosch, Kurt Strand
  • Patent number: 6022542
    Abstract: This invention relates to polynucleotides encoding Glycoprotein B from the RFHV/KSHV subfamily of gamma herpes viruses, three members of which are characterized in detail. DNA extracts were obtained from Macaque nemestrina and Macaque mulatta monkeys affected with retroperitoneal fibromatosis (RF), and human AIDS patients affected with Kaposi's sarcoma (KS). The extracts were amplified using consensus-degenerate oligonucleotide probes designed from known protein and DNA sequences of gamma herpes viruses. The nucleotide sequences of a 319 base pair fragment are about 76% identical between RFHV1 and KSHV, and about 60-63% identical with the closest related gamma herpes viruses outside the RFHV/KSHV subfamily. Protein sequences encoded within these fragments are are about 91% identical between RFHV1 and KSHV, and <.about.65% identical to that of other gamma herpes viruses.
    Type: Grant
    Filed: September 26, 1996
    Date of Patent: February 8, 2000
    Assignee: University of Washington
    Inventors: Timothy M. Rose, Marnix L. Bosch, Kurt Strand
  • Patent number: 5965674
    Abstract: An improved process for the production of polyolefins in an autoclave reactor having several reaction zones operated at a pressure of 100 to 300 MPa and a temperature of 100 to 300.degree. C. is disclosed. Dunng operation, temperatures are measured continuously inside the autoclave reactor at specific points distributed along the reactor length, each of said measured temperatures is compared with a corresponding preset temperature and the detected deviation between each pair of preset and measured temperatures is used in regulating the amount of monomer and initiator fed into the autoclave through several feed inlets distributed along the reactor length, in order to minimize the temperature deviations and thus obtain an improved control of the polymerization process.
    Type: Grant
    Filed: July 24, 1996
    Date of Patent: October 12, 1999
    Assignee: Borealis Holding A/S
    Inventors: Oivind Moen, Mangor Lien, Lars Bjornar Lyngmo, Kurt Strand, Havard Nordhus, Peter Singstad, Jan Kjeldstad
  • Patent number: 5925733
    Abstract: This invention provides isolated polynucleotides encoding DNA polymerases of three members of a subfamily of gamma herpes viruses. Two were obtained from macaque monkeys affected with retroperitoneal fibromatosis, the other from human AIDS patients affected with Kaposi's sarcoma. A 454-base pair fragment encoding a region near the active site of the DNA polymerase is 69-83% identical amongst the three viruses, but only 54-68% identical with other known gamma herpes sequences and <55% identical with alpha and beta herpes sequences. Also provided are polynucleotides encoding DNA polymerase from related viruses in the RFHV/KSHV subfamily. Polynucleotides prepared according to the sequence data can be used as reagents to detect and characterize related sequences. Such reagents may be used to detect members of the RFHV/KSHV subfamily, including but not limited to RFHV, RFHV2, and KSHV. Corresponding polypeptides and peptide fragments may be obtained by expressing the polynucleotide or by chemical synthesis.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: July 20, 1999
    Assignee: University of Washington
    Inventors: Timothy M. Rose, Marnix L. Bosch, Kurt Strand, George J. Todaro
  • Patent number: 6015565
    Abstract: This invention relates to polynucleotides encoding Glycoprotein B from the RFHV/KSHV subfamily of gamma herpes viruses, three members of which are characterized in detail. DNA extracts were obtained from Macaque nemestrina and Macaque mulatta monkeys affected with retroperitoneal fibromatosis (RF), and human AIDS patients affected with Kaposi's sarcoma (KS). The extracts were amplified using consensus-degenerate oligonucleotide probes designed from known protein and DNA sequences of gamma herpes viruses. The nucleotide sequences of a 319 base pair fragment are about 76% identical between RFHV1 and KSHV, and about 60-63% identical with the closest related gamma herpes viruses outside the RFHV/KSHV subfamily. Protein sequences encoded within these fragments are are about 91% identical between RFHV1 and KSHV, and <.about.65% identical to that of other gamma herpes viruses.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: January 18, 1999
    Assignee: The University of Washington
    Inventors: Timothy M. Rose, Marnix L. Bosch, Kurt Strand